Literature DB >> 14090856

TETRACYCLINE IN THE TREATMENT OF CHOLERA.

W B GREENOUGH, R S GORDON, I S ROSENBERG, B I DAVIES, A S BENENSON.   

Abstract

Entities:  

Keywords:  CHOLERA; INFUSIONS, PARENTERAL; PAKISTAN; STATISTICS; TETRACYCLINE

Mesh：

Substances：

Year:  1964        PMID： 14090856     DOI： 10.1016/s0140-6736(64)92099-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  46 in total

1.  THE 1961 CHOLERA EPIDEMIC IN MANILA, REPUBLIC OF THE PHILIPPINES.

Authors:  C K WALLACE; A E FABIE; O MANGUBAT; E VELASCO; C JUINIO; R A PHILLIPS
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

Review 2.  INFECTIOUS DISEASES. ANNUAL REVIEW OF SIGNIFICANT PUBLICATIONS.

Authors:  H A REIMANN
Journal:  Postgrad Med J       Date:  1964-10       Impact factor: 2.401

3.  Phenotypic, genotypic, and antibiotic sensitivity patterns of strains isolated from the cholera epidemic in Zimbabwe.

Authors:  Mohammad S Islam; Zahid H Mahmud; Mohammad Ansaruzzaman; Shah M Faruque; Kaisar A Talukder; Firdausi Qadri; Munirul Alam; Shafiqul Islam; Pradip K Bardhan; Ramendra N Mazumder; Azharul I Khan; Sirajuddin Ahmed; Anwarul Iqbal; Owen Chitsatso; James Mudzori; Sheetal Patel; Stanley M Midzi; Lincoln Charimari; Hubert P Endtz; Alejandro Cravioto
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

Review 4.  Cholera.

Authors:  Jason B Harris; Regina C LaRocque; Firdausi Qadri; Edward T Ryan; Stephen B Calderwood
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

5.  C reactive protein and prealbumin as markers of disease activity in shigellosis.

Authors:  W A Khan; M A Salam; M L Bennish
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

6.  Antibiotic therapy of cholera.

Authors:  J Lindenbaum; W B Greenough; M R Islam
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

7.  Controlled comparison of tetracycline and furazolidone in cholera.

Authors:  N F Pierce; J G Banwell; R C Mitra; G J Caranasos; R I Keimowitz; J Thomas; A Mondal
Journal:  Br Med J       Date:  1968-08-03

8.  Effects of doxycycline in actively purging cholera patients: a double-blind clinical trial.

Authors:  M M Rahaman; M A Majid; M R Islam
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

9.  Drug response and genetic properties of Vibrio cholerae associated with endemic cholera in north-eastern Thailand, 2003-2011.

Authors:  Chariya Chomvarin; Fatema-Tuz Johura; Shahnewaj B Mannan; Warin Jumroenjit; Boonnapa Kanoktippornchai; Waraluk Tangkanakul; Napaporn Tantisuwichwong; Sriwanna Huttayananont; Haruo Watanabe; Nur A Hasan; Anwar Huq; Alejandro Cravioto; Rita R Colwell; Munirul Alam
Journal:  J Med Microbiol       Date:  2013-01-14       Impact factor: 2.472

10.  Emergence of multidrug-resistant strain of Vibrio cholerae O1 in Bangladesh and reversal of their susceptibility to tetracycline after two years.

Authors:  Abu S G Faruque; Khorshed Alam; Mohammad A Malek; Mohammed G Y Khan; Sabeena Ahmed; Debasish Saha; Wasif A Khan; Gopinath B Nair; Mohammed A Salam; Stephen P Luby; David A Sack
Journal:  J Health Popul Nutr       Date:  2007-06       Impact factor: 2.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.